$TOVX 8-K/A SEC Filings

Filed On	Filing
06 Sep 2022	8-K/A: Financial Statements and Exhibits On December 14, 2021, Synthetic Biologics, Inc. (the “Company” or the “Buyer”) entered into a Share Purchase Agreement (the “Agreement” or “SPA”) with VCN Biosciences, S.L. (“VCN”) and each of VCN’s shareholders (the “Sellers ”) pursuant...
06 May 2022	8-K/A: Completion of Acquisition or Disposition of Assets We have audited the financial statements of VCN Biosciences, S.L. (the Company), which comprise the statements of financial position as of December 31, 2021 and 2020, and the related statements of profit and loss and other comprehensive ...
12 Feb 2021	8-K/A: Unregistered Sales of Equity Securities
01 Feb 2021	8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders +1 more
30 May 2012	8-K/A: Non-Reliance on Previously Issued Financial Statements
03 Feb 2012	8-K/A: Financial Statements and Exhibits
31 Mar 2010	8-K/A: Departure/Election of Directors or Officers; Compensation
19 Oct 2009	8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
24 Sep 2009	8-K/A: Completion of Acquisition or Disposition of Assets
07 Nov 2006	8-K/A: Entry into a Material Definitive Agreement; Changes in Registrant's Certifying Accountant +3 more
21 Dec 2001	8-K/A: Other Events

Comments